The largest database of trusted experimental protocols

Proswift rp 4h

Manufactured by Thermo Fisher Scientific
Sourced in Germany

The ProSwift RP-4H is a reversed-phase high-performance liquid chromatography (HPLC) column. It is designed for the separation and purification of various biomolecules, such as peptides, proteins, and oligonucleotides. The column features a monolithic silica-based stationary phase, which provides high permeability and fast mass transfer, enabling efficient and high-resolution separations.

Automatically generated - may contain errors

4 protocols using proswift rp 4h

1

Paenithopeptin Mass Spectrometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
A Thermo Scientific Q-Exactive HF-X hybrid Quadrupole-Orbitrap mass spectrometer was used for the high-resolution ESI-MS spectra and CID-MS/MS analysis of paenithopeptins using electrospray ionization in the positive ion mode. Liquid chromatography was performed on a Thermo Vanquish HPLC interfaced to the aforementioned mass spectrometer. A Thermo Scientific ProSwift RP-4H reversed phased monolith column with dimensions 1 × 250 mm was used for the separation. Solvent A was 0.1% formic acid in water and Solvent B was 0.1% formic acid in acetonitrile, with the flow rate being 200 μL/min. The LC gradient used started at 10% B for 1 min then increased to 100% B over 10 min where it remained for 5 min. MS1 scans were obtained in the orbitrap analyzer which scanned from 500–2000 m/z at a resolution of 60,000 (at 200 m/z). For collision-induced dissociation tandem mass spectrometry (CID-MS/MS), the relevant parent ion was selected with a 2 m/z window and fragmented by CID, using normalized collision energies of 20, 25 & 30 eV (results were combined into one spectrum). Fragment ions were then sent to the Orbitrap for mass analysis at 30,000 resolution. The MS data was analyzed by Thermo Xcalibur (4.2.47).
+ Open protocol
+ Expand
2

Mass Spectrometric Analysis of Deglycosylated EPO

Check if the same lab product or an alternative is used in the 5 most similar protocols
EPO was denatured, reduced, alkylated and digested by PNGase F as
mentioned above. de-N-Glycosylated EPO samples were injected into
a LC system (Waters ACQUITY, Milford, MA, USA), coupled with a hybrid
quadrupole-orbitrap mass spectrometer. Solvent A was 0.1% FA in water,
and solvent B was 0.1% FA in ACN. Using a RP monolithic column (ProSwift
RP-4H, 1 × 250 mm, Thermo Fisher Scientific, Bremen, Germany),
solvent B started with 5% for a duration of 2 min, increasing to 25%
in 7 min, and to 60% in 34 min at a flow rate of 0.2 mL/min. Detailed
MS instrument parameters are described in the Supporting Information.
To deconvolute the MS raw data,
the parameters of BioPharma Finder were set as follows: the amino
acid sequence of epoetin beta was used as a FASTA database; the oxidation
of methionine and carbamidomethylation of cysteine residues were included
as variable modifications; the deamidation on Asn-24, Asn-38, and
Asn-83 was set as a static modification. For the processing method,
the m/z range was set from 1500 to 3000; Xtract (isotopically resolved)
was used as a deconvolution algorithm; the output mass range was set
from 16,000 to 30,000; charge states between 8 and 25 were considered,
and a minimum number of 6 was used for deconvolution; the mass tolerance
was set to 20 p.p.m..
+ Open protocol
+ Expand
3

Phosphorylation Status Verification of Recombinant p-MLKL

Check if the same lab product or an alternative is used in the 5 most similar protocols
To verify the phosphorylation status of recombinant p-MLKL pseudokinase domain, the purified proteins were separated by reverse-phase chromatography on a 25 cm ProSwift RP-4H monolith column (Thermo Scientific) using a micro-flow HPLC (M-class, Waters). The HPLC was coupled to an Impact II QTOF mass spectrometer (Bruker) equipped with an ESI source. Proteins were loaded directly onto the column for online buffer exchange at a constant flow rate of 30 μL/min with buffer A (99.9% Milli-Q water, 0.1% formic acid (FA)) using a trap-valve to direct flow to waste. After 10 min, the trap valve was switched to direct flow to the mass spectrometer, and proteins were eluted with a 15-min linear gradient from 2 to 90% buffer B (99.9% acetonitrile (ACN), 0.1% FA). The Impact II QTOF was operated in mode using Compass Hystar 5.1. Settings for the 40 samples per day method were as follows: Mass Range 100 to 3000 m/z, Capillary Voltage 4500 V, Dry Gas 4 L/min, Dry Temp 200 °C.
+ Open protocol
+ Expand
4

Quantitative Proteomics of Synthetic Peptides

Check if the same lab product or an alternative is used in the 5 most similar protocols
Each peptide was analyzed by LC-MS using a Q Exactive Focus mass spectrometer (Thermo Fisher Scientific). Peptide separation was performed on Ultimate 3000 nanoHPLC and Vanquish ultra-high-performance liquid chromatography systems. The C1, C1MC1, and C2MC2 peptides were analyzed using a Proswift RP4H (Thermo Fisher) monolithic nanocolumn (0.1 × 250 mm), and the C2MC1 and C1MC2 peptides were analyzed using a Zorbax Eclipse Plus C18 Rapid Resolution HT column (2 × 50 mm, 1.8 μm, 95 Å). Acetonitrile gradients between 10%–30% and 15%–25% in formic acid (0.1%) were used. Mass analysis was performed at a resolution of 35,000 (m/z, 200) with a MS range of 500–1300 and MS/MS analysis. The collision energy was optimized for each peptide (between 22% and 25%) to reduce formation of internal fragments. The lock mass option was activated to enhance mass accuracy. For each peptide, several scans (between 5 and 10) were merged to enhance the quality of the data. Data were deconvoluted using Xtract tools included in the Freestyle software suite, version 1.3 (Thermo Electron). All daughter ions observed were verified and annotated manually.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!